Data-driven brain atrophy staging in spinocerebellar ataxia type 3
Preprint
Abstract
Spinocerebellar ataxia type 3 (SCA3) is the most common autosomal dominant ataxia worldwide. First targeted gene therapy trials have started, offering the intriguing scenario of preventive treatment. SCA3 is associated with progressive regional brain atrophy that starts before clinical manifestation. We aimed to identify the spatiotemporal progression pattern of brain atrophy of SCA3 with a focus on early disease stages. T1-weighted MRI scans of 300 SCA3 mutation carriers and 317 controls were analyzed. Subtype and Stage Inference (SuStaIn) was used to identify the sequence of volume loss across selected brain regions. We observed one distinct sequence of brain atrophy events in SCA3 without evidence for the existence of alternative cascades. Atrophy started in the most caudal parts of the brainstem. Almost all preataxic SCA3 mutation carriers clustered in the first atrophy stages. Certainty of sequence estimation was highest for early atrophy stages with prominent involvement of the pons and cerebellar white matter. Brain atrophy in SCA3 follows a clear and distinct sequence ascending from the lower brainstem with an early involvement of white matter. Knowledge of this sequence might support the stratification of SCA3 mutation carriers with an imminent clinical onset for early interventions.Keywords
This publication has 32 references indexed in Scilit:
- Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 MiceAnnals of Neurology, 2023
- The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJDJournal of Neurology, 2023
- Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3Annals of Neurology, 2022
- Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3Movement Disorders, 2021
- A 5‐Year Longitudinal Clinical and Magnetic Resonance Imaging Study in Spinocerebellar Ataxia Type 3Movement Disorders, 2020
- Structural signature of SCA3: From presymptomatic to late disease stagesAnnals of Neurology, 2018
- Altered structural network organization in cognitively normal individuals with amyloid pathologyNeurobiology of Aging, 2018
- Inventory of Non-Ataxia Signs (INAS): Validation of a New Clinical Assessment InstrumentThe Cerebellum, 2012
- Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6NeuroImage, 2010
- A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volumeNeuroImage, 2004